Back
ESC Premium Access

Improving cardiovascular outcomes in patients with type 2 diabetes: our clinical experience with empagliflozin.

Session: Improving cardiovascular outcomes in patients with type 2 diabetes: our clinical experience with empagliflozin
Topic: Diabetes, dysglycaemia and metabolic syndrome
Speaker: Professor D. McGuire (Dallas, US) Professor J. Gonzalez Juanatey (Santiago de Compostela, ES)
Sponsored by Boehringer Ingelheim & Eli Lilly and Company Diabetes Alliance
Event: ESC Congress 2017

Congress Presentation

Add to my library

Like

About the speakers

Professor Darren Keith McGuire

University of Texas Southwestern Medical Center, Dallas (United States of America)
21 presentations
0 follower

Professor Jose Ramon Gonzalez Juanatey

University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)
24 presentations
4 followers

Access the full session

Improving cardiovascular outcomes in patients with type 2 diabetes: our clinical experience with empagliflozin

Speakers: Professor D. McGuire, Professor J. Gonzalez Juanatey
Access
Like
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources